Manufacturers Life Insurance Company, The Altimmune, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Altimmune, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 25,660 shares of ALT stock, worth $116,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,660
Previous 26,328
2.54%
Holding current value
$116,753
Previous $161,000
14.91%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ALT
# of Institutions
211Shares Held
39.4MCall Options Held
1.93MPut Options Held
1.4M-
Black Rock Inc. New York, NY5.32MShares$24.2 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.25MShares$23.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$20.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$15.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$12.5 Million1.49% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $223M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...